Researchers at the Perelman School of Medicine at the University of Pennsylvania are launching a $12.5 million study to improve postpartum blood pressure management and long-term cardiovascular health for patients with hypertensive disorders during pregnancy.
AstraZeneca on ‘independent’ manufacturing; Samsung Bio’s next ADC deal
Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more. AstraZeneca CEO Pascal Soriot said